Evidence map›Paper›PMID 29505892›Full record

ArticleActa biomaterialia2018

Crystallinity of hydroxyapatite drives myofibroblastic activation and calcification in aortic valves.

Jennifer M Richards, Jennie A M R Kunitake, Heather B Hunt, Alexa N Wnorowski, Debra W Lin, Adele L Boskey, Eve Donnelly, Lara A Estroff, Jonathan T Butcher

Abstract read
In one paragraph

Article in Acta biomaterialia, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
4.1field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 40 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Pre-glycation impairs gelation of high concentration collagen solutions.Journal of biomedical materials research. Part A · 2022
    Article
  7. Review
  8. Review
  9. Calciprotein Particles: Balancing Mineral Homeostasis and Vascular Pathology.Arteriosclerosis, thrombosis, and vascular biology · 2021
    Review
  10. Review
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Jennifer M RichardsDepartment of Biomedical Engineering, Cornell University, Ithaca, NY, USA.
Jennie A M R KunitakeDepartment of Materials Science and Engineering, Cornell University, Ithaca, NY, USA.
Heather B HuntDepartment of Materials Science and Engineering, Cornell University, Ithaca, NY, USA.
Alexa N WnorowskiDepartment of Biomedical Engineering, Cornell University, Ithaca, NY, USA.
Debra W LinDepartment of Materials Science and Engineering, Cornell University, Ithaca, NY, USA.
Adele L BoskeyMusculoskeletal Integrity Program, Hospital for Special Surgery, New York, NY, USA.
Eve DonnellyDepartment of Materials Science and Engineering, Cornell University, Ithaca, NY, USA; Musculoskeletal Integrity Program, Hospital for Special Surgery, New York, NY, USA.
Lara A EstroffDepartment of Materials Science and Engineering, Cornell University, Ithaca, NY, USA; Kavli Institute for Nanoscale Science, Cornell University, Ithaca, NY 14853, USA.
Jonathan T ButcherDepartment of Biomedical Engineering, Cornell University, Ithaca, NY, USA. Electronic address: jtb47@cornell.edu.
Cornell University · USHospital for Special Surgery · US

Funding

Adhesive signaling in aortic valve development and diseaseR01HL128745 · NHLBI · CORNELL UNIVERSITY · PI BUTCHER, JONATHAN TALBOT · 2015 to 2018
$1.5M
Effects of hydroxyapatite mineralization and valve cell phenotypeR21HL118672 · NHLBI · CORNELL UNIVERSITY · PI BUTCHER, JONATHAN TALBOT · 2013 to 2014
$405k
NHLBI NIH HHS R01 HL128745NHLBI NIH HHS R21 HL118672
6 · The paper itself

Abstract

Calcific aortic valve disease (CAVD) is an inexorably degenerative pathology characterized by progressive calcific lesion formation on the valve leaflets. The interaction of valvular cells in advanced lesion environments is not well understood yet highly relevant as clinically detectable CAVD exhibits calcifications composed of non-stoichiometric hydroxyapatite (HA). In this study, Fourier transform infrared spectroscopic imaging was used to spatially analyze mineral properties as a function of disease progression. Crystallinity (size and perfection) increased with increased valve calcification. To study the relationship between crystallinity and cellular behavior in CAVD, valve cells were seeded into 3D mineral-rich collagen gels containing synthetic HA particles, which had varying crystallinities. Lower crystallinity HA drove myofibroblastic activation in both valve interstitial and endothelial cells, as well as osteoblastic differentiation in interstitial cells. Additionally, calcium accumulation within gels depended on crystallinity, and apoptosis was insufficient to explain differences in HA-driven cellular activity. The protective nature of endothelial cells against interstitial cell activation and calcium accumulation was completely inhibited in the presence of less crystalline HA particles. Elucidating valve cellular behavior post-calcification is of vital importance to better predict and treat clinical pathogenesis, and mineral-containing hydrogel models provide a unique 3D platform to evaluate valve cell responses to a later stage of valve disease. STATEMENT OF SIGNIFICANCE: We implement a 3D in vitro platform with embedded hydroxyapatite (HA) nanoparticles to investigate the interaction between valve interstitial cells, valve endothelial cells, and a mineral-rich extracellular environment. HA nanoparticles were synthesized based on analysis of the mineral properties of calcific regions of diseased human aortic valves. Our findings indicate that crystallinity of HA drives activation and differentiation in interstitial and endothelial cells. We also show that a mineralized environment blocks endothelial protection against interstitial cell calcification. Our HA-containing hydrogel model provides a unique 3D platform to evaluate valve cell responses to a mineralized ECM. This study additionally lays the groundwork to capture the diversity of mineral properties in calcified valves, and link these properties to progression of the disease.

Indexed as

Cell DifferentiationAortic ValveDurapatiteEndothelial CellsHumansMyofibroblastsOsteoblastsVascular CalcificationDurapatiteEndothelialFTIRHydroxyapatite nanoparticlesInterstitialPathological biomineralizationValve calcification

Identifiers

PMID29505892
PMCPMC5899951
OpenAlexW2790345786

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.